================================================================================
---------------------------------------------------------
Filed By Allscripts Inc. (Commission File No. 000-26537)
Pursuant to rule 425 under the Securities Act of 1933 and
deemed filed pursuant to Rule 14A-12 of the Securities
Exchange Act of 1934
Subject Company: ChannelHealth Incorporated
---------------------------------------------------------
FOR IMMEDIATE RELEASE
ALLSCRIPTS CONTACT IDX SYSTEMS CONTACT
Ken Shore Margo Happer
Vice President - Marketing Director - Investor Relations
(847) 680-3515, ext. 200 (802) 864-1758, ext. 6169
e-mail: info@allscripts.com e-mail: margo_happer@idx.com
------------------- --------------------
CHANNELHEALTH CONTACT
Tracey Moran
(802) 863-5525, ext. 4272
e-mail: tracey_moran@channelhealth.com
------------------------------
ALLSCRIPTS FILES S-4 FOR COMPLETION
OF CHANNELHEALTH ACQUISITION
- --------------------------------------------------------------------------------
CHICAGO, IL, AND BURLINGTON, VT, NOVEMBER 9, 2000 - Allscripts, Inc. (NASDAQ:
MDRX), the leading provider or wireless, point-of-care e-prescribing and
productivity solutions for physicians, and IDX Systems Corporation (NASDAQ:
IDXC), a leading healthcare information systems company, today announced that
Allscripts has filed an SEC Form S-4 registration statement in connection with
the pending purchase of ChannelHealth Incorporated by Allscripts. ChannelHealth,
a subsidiary of IDX, provides a set of Internet-based clinical and productivity
solutions for physicians that bring the power of the Internet to the practice of
medicine.
"We are pleased to have taken another significant step in the completion of our
acquisition of ChannelHealth," stated Glen Tullman, Chairman and Chief Executive
Officer of Allscripts. "Customer feedback on the merger has been very positive.
Our initial discussions with large IDX clients have already created a pipeline
of over 30 potential customers representing in excess of 5,200 physicians."
"We are very excited to integrate point-of-care tools into our practice
management systems," commented Richard E. Tarrant, Chief Executive Officer of
IDX. "We continue to receive enthusiastic responses from our customers for the
Allscripts component of our overall solution."
ABOUT ALLSCRIPTS
Allscripts is improving healthcare at the point-of-care. As the leading provider
of innovative point-of-care medication management and productivity enhancing
solutions, Allscripts focuses on addressing the needs of physicians and managed
care payers and plans. Allscripts' TouchScript software provides easy-to-use
electronic prescribing that reduces medication errors and uses the Internet to
route transactions to local retail, mail order and Internet pharmacies, and
provide connectivity to managed care and other organizations. Allscripts also
offers physicians the opportunity to dispense commonly prescribed medications to
their patients at the point-of-care. TouchScript software and applications run
on Microsoft's PocketPC and Windows CE operating systems. Allscripts provides
its applications on the Compaq iPAQ and the Hewlett-Packard Jornada hand-held
wireless hardware. Allscripts also provides a number of Internet-based patient
compliance and physician education services such as its e-Detailing(TM) products
from its Physicians Interactive unit, as well as e-commerce applications.
Through its acquisition of MasterChart, Allscripts markets innovative hand-held
digital dictation solutions for physicians. Allscripts also allows physicians to
access and prescribe patient care plans, directly in the office and over the
Internet, through its Medifor unit. Strategic partners include IMS Health (NYSE:
RX), the world's leading supplier of information solutions to the pharmaceutical
and healthcare industries, Express Scripts, the nation's largest independent
full-service pharmacy benefit manager, and Dendrite, a leading global provider
of highly specialized, integrated product and service offerings for the
pharmaceutical industry. Allscripts is headquartered in Libertyville, IL, and
provides services to over 13,500 physicians at 3,500 sites across the U.S. Visit
Allscripts on the Web at allscripts.com. Allscripts, TouchScript,
TouchScript.Net, Personal Prescriber and 3Touch are trademarks of Allscripts,
Inc.
ABOUT IDX
Founded in 1969, IDX Systems Corporation uses information technology to maximize
value in the delivery of healthcare, improve the quality of patient service,
enhance medical outcomes, and reduce the costs of care. IDX supports these
objectives with a broad range of complementary, functionally rich, and highly
integrated products installed at 2,065 client sites. Clients span the full care
continuum including academic hospitals and medical centers, integrated delivery
networks, and physician group practices in North America and the United Kingdom.
Customers include 118,000 physicians who utilize practice management systems to
improve patient care and other work flow processes. The IDX Web Strategy
includes browser technology, e-commerce and web-based tools -- built using
Internet architecture -- that facilitates access for patients, physicians and
care providers to vital health information and data managed by the IDX clinical,
administrative, financial, and managed care products. EDiX Corporation, an IDX
subsidiary, offers Internet-based medical transcription and clinical
documentation services to physicians groups and hospital customers.
This announcement contains forward-looking statements about Allscripts, Inc.
that involve risks and uncertainties. These forward-looking statements are
developed by combining currently available information with Allscripts' beliefs
and assumptions. These statements often contain words like will, believe,
expect, anticipate, intend, contemplate, seek, plan, estimate or similar
expressions. Forward-looking statements do not guarantee future performance.
These statements are made under the protection afforded them by Section 21E of
the Securities Exchange Act of 1934. Because Allscripts cannot predict all of
the risks and uncertainties that may affect it, or control the ones it does
predict, Allscripts' actual results may be materially different from the results
2
expressed in its forward-looking statements. For a more complete discussion of
the risks, uncertainties and assumptions that may affect Allscripts, see
Allscripts' 1999 Annual Report on Form 10-K, the registration statement filed in
connection with the merger with ChannelHealth and the proxy statement to be
filed in connection with the merger with ChannelHealth. Such documents can be
obtained through the website maintained by the Securities and Exchange
Commission at www.sec.gov.
This press release contains forward-looking statements about IDX Systems
Corporation that involve a number of risks and uncertainties. Among the
important factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are difficulties in
implementing systems, possible deferral, delay or cancellation by customers of
computer system purchase decisions, possible delay or denial of stockholder or
regulatory approval for the transactions with Allscripts, Inc., possible adverse
change in the business or stock price of Allscripts, Inc., possible delay of
system installations, development by competitors of new or superior
technologies, changing economic, political and regulatory influences on the
healthcare and Internet industries, changes in product pricing policies, general
economic conditions and regulatory developments in the healthcare industry, and
factors detailed from time to time in IDX's periodic reports and registration
statements filed with the Securities and Exchange Commission, which important
factors are incorporated herein by reference. IDX undertakes no obligation to
update forward-looking statements to reflect changed assumptions, the occurrence
of unanticipated events, or changes in future operating results, financial
condition or business over time.
Allscripts has filed a Registration Statement on Form S-4 in connection with the
merger transactions referred to in this press release, and Allscripts will be
mailing a Proxy Statement/Prospectus to its stockholders containing information
about the merger. We urge investors and stockholders to read the registration
statement and proxy statement/prospectus carefully when they become available,
because they contain important information concerning Allscripts, ChannelHealth,
the merger and related matters. Investors and security holders are able to
obtain free copies of the registration statement on form S-4 and the proxy
statement/prospectus through the website maintained by the Securities and
Exchange Commission at www.sec.gov. and from Allscripts at the contact listed
above.
Allscripts and its directors and certain of its executive officers may be
deemed, under SEC rules, to be soliciting proxies from its stockholders in favor
of the proposed merger. Information regarding the identity of these persons, and
their interest in the solicitation, will be set forth in a schedule 14a to be
filed with the SEC, and available free of charge at the SEC website and public
reference room, and from Allscripts as provided above.
3